Should adult medulloblastoma patients at low risk receive adjuvant chemotherapy? Long-term results of a prospective study

MLA

Alicia Tosoni, et al. “Should Adult Medulloblastoma Patients at Low Risk Receive Adjuvant Chemotherapy? Long-Term Results of a Prospective Study.” Journal of Clinical Oncology, vol. 25, June 2007, p. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cd9b42eb4a0c76a3822c38afed8dc745&authtype=sso&custid=ns315887.

APA

Alicia Tosoni, Stefania Bartolini, Aa Brandes, Enrico Franceschi, P. Amista, M. Ermani, L. M. Pasetto, Guido Sotti, V. Blatt, & D. Grosso. (2007). Should adult medulloblastoma patients at low risk receive adjuvant chemotherapy? Long-term results of a prospective study. Journal of Clinical Oncology, 25, 2018.

Chicago

Alicia Tosoni, Stefania Bartolini, Aa Brandes, Enrico Franceschi, P. Amista, M. Ermani, L. M. Pasetto, Guido Sotti, V. Blatt, and D. Grosso. 2007. “Should Adult Medulloblastoma Patients at Low Risk Receive Adjuvant Chemotherapy? Long-Term Results of a Prospective Study.” Journal of Clinical Oncology 25 (June): 2018. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........cd9b42eb4a0c76a3822c38afed8dc745&authtype=sso&custid=ns315887.